Sessions have been announced for the 7th annual Access to Innovation Conference. The virtual conference brings together all stakeholders in the life sciences sector, academia, research, health institutions, and government to share their insights into this year’s theme: Building on Excellence: A Vibrant Future for BC Life Sciences.
We are pleased to announce that IRICoR is a partner […]

 
The new issue of Premières en affaires magazine is now available. IRICoR is proud to have collaborated on this edition.
 
Nadine Beauger, President and CEO of IRICoR and Anne Marinier, Director of Medicinal Chemistry and Director of the Drug Discovery Unit at IRIC, highlight the strength of a collaborative women and the importance of combining science and business, for the ultimate […]

IRICoR is very pleased to announce the appointment of Mrs Narjes Achach, as an Intellectual Property Analyst. In this role, Ms. Achach will provide support for intellectual property (IP) activities, will be called upon to maintain the IP portfolio and carry out preliminary research important to the development of projects. She will work closely with the Senior Intellectual Property Manager.
Prior […]

On Monday, December 13, Nadine Beauger, IRICoR’s President and CEO, took part in the panel discussion: Leveraging our niches of excellence, along with Stéphane Létourneau, Executive Vice President at Mila, and Stéphane Paquet, President and CEO at Montréal International. This panel was presented as part of the Strategic Forum: The pharmaceutical industry: At the forefront of life sciences, an initiative […]

Martinsried, Germany and Montréal, Canada – Medigene AG (Medigene, FSE: MDG1, Prime Standard), a clinical-stage immuno-oncology company focusing on the development of T cell immunotherapies, IRICoR, and the University of Montréal (Université de Montréal, UdeM) expand their mutual analyses of potentially novel cancer antigens.
In January 2020, Medigene entered into a research collaboration on novel cancer antigens for highly specific immunotherapies […]

On November 22nd, Nadine Beauger, President and Chief Executive Officer of IRICoR, was invited as a panellist at the 13th Canadian Science Policy Conference, presented by the Canadian Science Policy Centre (CSPC). For this occasion, Nadine participated in the session “Realizing Canada’s Life Sciences Opportunities,” moderated by Gordon C. McCauley, President & CEO of adMare BioInnovations, along with Cate Murray, […]

In 2020, IRICoR concluded a major partnership with Ovarian Cancer Canada. By launching the pan-Canadian LeadAction Ovarian Cancer Competition, the 5th call for projects at IRICoR, these organizations aimed to fund innovative ovarian cancer research projects to accelerate the discovery of new treatments.
A few months ago, the winners of the Competition were announced. A total amount of $2.3M over two (2) years […]

IRICoR is delighted by the commitment made by the ministère de l’Économie et de l’Innovation (MEI) in creating “Médicament Québec”, a major strategic hub whose mission is to promote greater autonomy and increase Quebec’s drive in drug discovery, development and production.
This large-scale project led by Université de Montréal, and got off the ground thanks to $13M in funding from the MEI. Through […]

At a recent special evening to mark the 30th anniversary of BIOQuébec, the organization welcomed the appointment of three new members to its board of directors. IRICoR is therefore pleased to announce the appointment of its President and CEO, Ms. Nadine Beauger, to the Board of Directors of BIOQuébec.
BIOQuébec is the largest Quebec network in biotechnology and life sciences. The […]

SCIENTIFIC COLLABORATION YIELDS NEW HOPE FOR CHILDREN AFFECTED BY RARE BLOOD DISORDER
 
The Alberta-based Canadian Glycomics Network (GlycoNet), which develops new carbohydrate-based drugs, vaccines and diagnostics, joined forces with Quebec-based IRICoR, a group that specializes in drug discovery and commercialization. Both are part of Canada’s Networks of Centres of Excellence program, which fosters academic, government and industry partnerships […]